CABERLEE 0.5 - John Lee

Cabergoline has shown efficacy in managing lactation suppression, providing a safe option for stopping milk production when medically necessary. By acting specifically on D2 dopamine receptors, it lowers prolactin levels, thereby halting lactation without disrupting other hormonal processes. This precision in targeting prolactin release has made Cabergoline valuable in clinical contexts requiring controlled hormonal adjustments. Due to its ergot derivative composition, Cabergoline offers an effective option with minimized systemic side effects, making it preferable over less specific prolactin inhibitors in various therapeutic settings​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about CABERLEE 0.5 by John Lee, consult with your doctor or healthcare professional.